[go: up one dir, main page]

BR0014633A - Processo para isolamento e/ou identificação de pelo menos uma substância quìmica ativa a partir de uma mistura de substâncias quìmicas e dispositivo para a realização do processo - Google Patents

Processo para isolamento e/ou identificação de pelo menos uma substância quìmica ativa a partir de uma mistura de substâncias quìmicas e dispositivo para a realização do processo

Info

Publication number
BR0014633A
BR0014633A BR0014633-1A BR0014633A BR0014633A BR 0014633 A BR0014633 A BR 0014633A BR 0014633 A BR0014633 A BR 0014633A BR 0014633 A BR0014633 A BR 0014633A
Authority
BR
Brazil
Prior art keywords
mixture
active
isolation
identification
chemicals
Prior art date
Application number
BR0014633-1A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR0014633A publication Critical patent/BR0014633A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/26—Conditioning of the fluid carrier; Flow patterns
    • G01N30/38—Flow patterns
    • G01N30/46—Flow patterns using more than one column
    • G01N30/466—Flow patterns using more than one column with separation columns in parallel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G01N30/06—Preparation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N2030/022—Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027—Liquid chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G01N30/06—Preparation
    • G01N2030/067—Preparation by reaction, e.g. derivatising the sample
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N2030/621—Detectors specially adapted therefor signal-to-noise ratio
    • G01N2030/625—Detectors specially adapted therefor signal-to-noise ratio by measuring reference material, e.g. carrier without sample
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8831—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Electrostatic Separation (AREA)
  • Centrifugal Separators (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Extraction Or Liquid Replacement (AREA)

Abstract

"PROCESSO PARA ISOLAMENTO E/OU IDENTIFICAçãO DE PELO MENOS UMA SUBSTANCIA QUìMICA ATIVA A PARTIR DE UMA MISTURA DE SUBSTâNCIAS QUìMICAS E DISPOSITIVO PARA A REALIZAçãO DO PROCESSO". A presente invenção refere-se a um processo para o isolamento e/ou a identificação de pelo menos uma substancia química ativa a partir da mistura de substâncias químicas ativas e inativas, o processo é caracterizado pelas seguintes etapas: a) adicionar o alvo à referida mistura e formar um complexo de alvo e pelo menos uma substância química ativa da mistura, b) separar o complexo das substâncias químicas inativas da mistura, e, ou c) liberar e isolar e/ou identificar pelo menos uma substância química ativa a partir do complexo separado ou d) identificar pelo menos uma substância química ativa da mistura ao subtrair do cromatograma da mistura de substâncias químicas ativas e inativas o cromatograma de substâncias químicas inativas que é obtido após a separação do complexo, e possivelmente liberar e isolar a pelo menos uma substância química ativa a partir do complexo separado.
BR0014633-1A 1999-09-22 2000-09-13 Processo para isolamento e/ou identificação de pelo menos uma substância quìmica ativa a partir de uma mistura de substâncias quìmicas e dispositivo para a realização do processo BR0014633A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19945351A DE19945351C2 (de) 1999-09-22 1999-09-22 Verfahren zum Auffinden und zur Isolierung pharmakologisch wirksamer Verbindungen aus Substanzgemischen
PCT/EP2000/008919 WO2001022078A1 (de) 1999-09-22 2000-09-13 Verfahren und vorrichtung zum auffinden und zur isolierung pharmakologisher verbindungen aus substanzgemischen

Publications (1)

Publication Number Publication Date
BR0014633A true BR0014633A (pt) 2002-08-20

Family

ID=7922864

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014633-1A BR0014633A (pt) 1999-09-22 2000-09-13 Processo para isolamento e/ou identificação de pelo menos uma substância quìmica ativa a partir de uma mistura de substâncias quìmicas e dispositivo para a realização do processo

Country Status (23)

Country Link
US (1) US7232690B1 (pt)
EP (1) EP1214589B1 (pt)
JP (1) JP4842477B2 (pt)
KR (1) KR100676154B1 (pt)
CN (1) CN100420945C (pt)
AR (1) AR025740A1 (pt)
AT (1) ATE268474T1 (pt)
AU (1) AU777927B2 (pt)
BR (1) BR0014633A (pt)
CA (1) CA2387999C (pt)
CZ (1) CZ2002990A3 (pt)
DE (2) DE19945351C2 (pt)
DK (1) DK1214589T3 (pt)
ES (1) ES2222230T3 (pt)
HU (1) HU227662B1 (pt)
IL (1) IL148823A0 (pt)
MX (1) MXPA02002992A (pt)
PL (1) PL202679B1 (pt)
PT (1) PT1214589E (pt)
TR (1) TR200200779T2 (pt)
TW (1) TWI245121B (pt)
WO (1) WO2001022078A1 (pt)
ZA (1) ZA200202396B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10125258A1 (de) 2001-05-23 2003-01-09 November Ag Molekulare Medizin Verfahren zur Bestimmung des Bindeverhaltens von an Ziel-Molekülen spezifisch bindenden Liganden
WO2006015797A2 (en) * 2004-08-09 2006-02-16 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Method for high-throughput screening of test molecules binding to target molecules
EP2118652B1 (en) 2006-12-26 2012-05-23 Brigham Young University Serum proteomics system and associated methods
KR102589887B1 (ko) 2022-08-11 2023-10-17 인포보스 주식회사 미지 물질 내 함유물질의 예측방법, 장치 및 프로그램

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948726A (en) * 1986-06-02 1990-08-14 Longoria Claude C Enzyme immunoassay based on membrane separation of antigen-antibody complexes
US5202421A (en) * 1988-12-27 1993-04-13 Mochida Pharmaceutical Co., Ltd. Anticoagulant substance obtained from urine and process for the preparation thereof
CA2075987A1 (en) * 1990-02-14 1991-08-15 Duane L. Venton Method for generating and screening useful peptides
AU8654891A (en) 1990-08-10 1992-03-02 Purdue Research Foundation Matrix sequential addition immunoassay
JPH06500396A (ja) * 1990-08-10 1994-01-13 パーセプティブ　バイオシステムズ　インコーポレイテッド サブトラクティブクロマトグラフィによる蛋白構造の定量分析およびモニタリング
DE69216520T2 (de) * 1991-03-28 1997-04-24 Perseptive Biosystems Inc Produktinformation in chromatographischem effluenten durch differenzbildung
DE69319593T2 (de) 1992-03-27 1998-12-17 Perseptive Biosystems, Inc., Cambridge, Mass. Schnelles hochempfindliches immunanalytisches durchfluss-nachweissystem
AU684510B2 (en) * 1993-05-28 1997-12-18 Chiron Corporation Method for selection of biologically active peptide sequences
US5491096A (en) 1993-12-27 1996-02-13 Eli Lilly And Company Antigen detection with affinity chromatography and parallel processing a control
US6030804A (en) * 1995-06-06 2000-02-29 Human Genome Sciences, Inc. Polynucleotides encoding G-protein parathyroid hormone receptor HLTDG74 polypeptides
EP0835446B1 (en) * 1995-06-26 2003-04-09 Perseptive Biosystems, Inc. High speed, automated, continuous flow, multi-dimensional molecular selection and analysis
US5824503A (en) * 1995-06-29 1998-10-20 Takara Shuzo Co, Ltd. Gene encoding endoglycoceramidase activator
ES2143848T3 (es) * 1996-01-23 2000-05-16 Rapigene Inc Metodos para detectar la fijacion de una pareja de ligandos con sensibilidad mejorada.
DE19629141A1 (de) * 1996-07-19 1998-04-16 Bayer Ag Verfahren und Vorrichtung zum Screening von Molekülen bezüglich ihres individuellen Bindungsverhaltens zu mindestens einem vorgegebenen Ligand
JPH1150724A (ja) * 1997-08-05 1999-02-23 Shinkansai Bearing Co Ltd 窓用ヒンジ
DE19757574A1 (de) * 1997-12-23 1999-06-24 Bayer Ag Verbesserte Doppelmetallcyanid-Katalysatoren für die Herstellung von Polyetherpolyolen
AUPP103497A0 (en) * 1997-12-19 1998-01-15 Panbio Pty Ltd Assay apparatus
US6077940A (en) * 1997-12-24 2000-06-20 Genentech, Inc. Free solution ligand interaction molecular separation method

Also Published As

Publication number Publication date
CN100420945C (zh) 2008-09-24
KR20020048413A (ko) 2002-06-22
AU777927B2 (en) 2004-11-04
WO2001022078A1 (de) 2001-03-29
CN1375058A (zh) 2002-10-16
IL148823A0 (en) 2002-09-12
EP1214589A1 (de) 2002-06-19
HUP0203686A2 (hu) 2003-03-28
JP4842477B2 (ja) 2011-12-21
US7232690B1 (en) 2007-06-19
ES2222230T3 (es) 2005-02-01
PL202679B1 (pl) 2009-07-31
JP2003510569A (ja) 2003-03-18
ZA200202396B (en) 2003-03-28
DE19945351A1 (de) 2001-07-12
DE50006696D1 (de) 2004-07-08
DK1214589T3 (da) 2004-10-11
PL357350A1 (en) 2004-07-26
CA2387999C (en) 2008-09-02
CZ2002990A3 (cs) 2002-07-17
PT1214589E (pt) 2004-09-30
AR025740A1 (es) 2002-12-11
TR200200779T2 (tr) 2002-09-23
MXPA02002992A (es) 2002-09-30
TWI245121B (en) 2005-12-11
CA2387999A1 (en) 2001-03-29
HU227662B1 (en) 2011-10-28
AU7286700A (en) 2001-04-24
DE19945351C2 (de) 2002-04-18
HUP0203686A3 (en) 2010-01-28
EP1214589B1 (de) 2004-06-02
KR100676154B1 (ko) 2007-01-31
ATE268474T1 (de) 2004-06-15

Similar Documents

Publication Publication Date Title
Sajiki et al. Sensitive method for the determination of bisphenol-A in serum using two systems of high-performance liquid chromatography
Walter et al. Endothelin‐1 increases 2‐arachidonoyl glycerol (2‐AG) production in astrocytes
AR240990A1 (es) Procedimiento para la separacion de moleculas de interes biologico,de una mezcla que las contiene."
ES2173469T3 (es) Composicion de eliminacion de oxigeno de varios componentes.
BR9914567A (pt) Tubo de extração em contracorrente para remover constituintes orgânicos voláteis dos produtos de reação, e, uso de um tubo de extração em contracorrente
AR003415A1 (es) Compuestos analogos de lactacistina, metodo para inhibir la proteolisis dependiente de proteasoma, metodo para identificar un proceso biologico mediado por proteolisis dependiente de proteasoma, uso de dichos compuestos para preparar un medicamento para tratar una condicion mediada por proteolisis dependiente de proteasoma.
Yasui et al. Effects of chronic acetyl-L-carnitine treatment on brain lipid hydroperoxide level and passive avoidance learning in senescence-accelerated mice
BRPI0511977A (pt) dispositivos e métodos para remover agentes alvo de uma amostra
DE69433136D1 (de) Nukleinsäure-isolierung
BR9900844A (pt) Método para microencapsulação de uma substância sólida
BR9912702A (pt) Composto e método para a prevenção e/ou para o tratamento de alergias
BR9509938A (pt) Processo para aumentar a biodisponibilidade de um agente farmacéutico formulação farmacéutica para tratar um mamifero sofrendo de hipoesteroidismo osteoporose asma composição de substáncia
Orhan et al. UPLC–TOF-MS analysis of Galium spurium towards its neuroprotective and anticonvulsant activities
BR9909312B1 (pt) processos para separar ácido acrìlico, e para preparar um acrilato, ou uma mistura de dois ou mais do mesmo.
BR9004790A (pt) Dispersoes aquosas de organopolissiloxanos e processo para sua preparacao
Zaima et al. Vasorelaxant effect of isoquinoline derivatives from two species of Popowia perakensis and Phaeanthus crassipetalus on rat aortic artery
PT820303E (pt) Analogos do peptido p277 e composicoes farmaceuticas que os compreendem, para tratamento ou diagnostico de diabetes
BR9908730A (pt) Processos para o isolamento retificativo e para a preparação de ácido (met) acrìlico
BR0212414A (pt) Recipiente
BR0014633A (pt) Processo para isolamento e/ou identificação de pelo menos uma substância quìmica ativa a partir de uma mistura de substâncias quìmicas e dispositivo para a realização do processo
PE20030035A1 (es) Composiciones y metodos para la deteccion de biomarcadores relacionados con la enfermedad cardiovascular
BR0209512A (pt) Processo integrado para a preparação de compostos aromáticos substituìdos com alquila e alquenila
BR0212260A (pt) Agente antimicrobiano
BR9808011A (pt) Processo para a purificação de caprolactama
DE69714856D1 (de) Pharmazeutische zusammensetzung enthaltend einen embryonalen extrakt und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]

Free format text: E EM CONSONANCIA COM A RESOLUCAO NO 34 DO CGEN.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements